Despite many children experiencing fatigue after childhood brain injury, little is known about the predictors of this complaint. To date, traditional indices of traumatic brain injury (TBI) severity have not predicted reliably persisting fatigue (up to three years post-injury). This study aimed to establish whether persisting fatigue is predicted by serum biomarker concentrations in child TBI. We examined whether acute serum biomarker expression would improve prediction models of 12-month fatigue based on injury severity. Blood samples were collected from 87 children (1–17 years at injury) sustaining mild to severe TBI (Glasgow Coma Scale [GCS] range 3–15; mean 12.43; classified as mild TBI [n = 50, 57%] vs. moderate/severe TBI [n = 37, 43%]), and presenting to the emergency departments (ED) and pediatric intensive care units (PICU) at one of three tertiary pediatric hospitals (Royal Children's Hospital (RCH); Hospital for Sick Children (HSC), Toronto; St Justine Children's Hospital (SJH), Montreal). Six serum biomarker concentrations were measured within 24 h of injury (interleukin-6, interleukin-8 [IL-8], soluble vascular cell adhesion molecule [SVCAM], S100 calcium binding protein B [S100B], neuron specific enolase [NSE], and soluble neural cell adhesion molecule [sNCAM]). Fatigue at 12 months post-injury was measured using the Pediatric Quality of Life Inventory Multidimensional Fatigue Scale (parent report), classified as present/absent using previously derived cut-points. At 12 months post-injury, 22% of participants experienced fatigue. A model including IL-8 was the best serum biomarker for estimating the probability of children experiencing fatigue at 12 months post-injury. The IL-8 also significantly improved predictive models of fatigue based on severity.
Get full access to this article
View all access options for this article.
References
1.
DewanM.C., MummareddyN., WellonsJ.C., and BonfieldC.M. (2016). Epidemiology of global pediatric traumatic brain injury: qualitative review. World Neurosurg. 91, 497–509.e1.
2.
FalkA.C. (2013). A nurse-led paediatric head injury follow-up service. Scand. J. Caring Sci. 27, 51–56.
3.
BelmontA., AgarN., HugeronC., GallaisB., and AzouviP. (2006). Fatigue and traumatic brain injury. Ann. Readapt. Med. Phys. 49, 283–286.
4.
ZiinoC., and PonsfordJ. (2005). Measurement and prediction of subjective fatigue following traumatic brain injury. J. Int. Neuropsychol. Soc. 11, 416–425.
5.
CantorJ.B., AshmanT., GordonW., GinsbergA., EngmannC., EganM., SpielmanL., DijkersM., and FlanaganS. (2008). Fatigue after traumatic brain injury and its impact on participation and quality of life. J. Head Trauma Rehabil. 23, 41–51.
6.
BaumannC.R., WerthE., StockerR., LudwigS., and BassettiC.L. (2007). Sleep-wake disturbances 6 months after traumatic brain injury: a prospective study. Brain, 130, 1873–1883.
7.
OlverJ.H., PonsfordJ.L., and CurranC.A. (1996). Outcome following traumatic brain injury: a comparison between 2 and 5 years after injury. Brain Inj. 10, 841–848.
8.
EddyL., and CruzM. (2007). The relationship between fatigue and quality of life in children with chronic health problems: a systematic review. J. Spec. Pediatr. Nurs. 12, 105–114.
9.
ShenJ., BarberaJ., and ShapiroC.M. (2006). Distinguishing sleepiness and fatigue: focus on definition and measurement. Sleep Med. Rev. 10, 63–76.
10.
WilkinsonJ., MarmolN.L., GodfreyC., WillsH., van EijndhovenQ., BotchwayE.N., SoodN., AndersonV., and CatroppaC. (2018). Fatigue following paediatric acquired brain injury and its impact on functional outcomes: a systematic review. Neuropsychol. Rev. 28, 73–87.
11.
GreenhamM., GordonA.L., CooperA., DitchfieldM., ColemanL., HuntR.W., MackayM.T., MonagleP,. and AndersonV. (2018). Social functioning following pediatric stroke: contribution of neurobehavioral impairment. Dev. Neuropsychol. 43, 312–328.
12.
MollayevaT., KendzerskaT., MollayevaS., ShapiroC.M., ColantonioA., and CassidyJ.D. (2014). A systematic review of fatigue in patients with traumatic brain injury: the course, predictors and consequences. Neurosci. Biobehav. Rev. 47, 684–716.
13.
PonsfordJ., ZiinoC., ParcellD.L., ShekletonJ.A., RoperM., RedmanJ.R., Phipps-NelsonJ., and RajaratnamS.M. (2012). Fatigue and sleep disturbance following traumatic brain injury—their nature, causes, and potential treatments. J. Head Trauma Rehabil. 27, 224–233.
14.
HutchisonM., MainwaringL.M., ComperP., RichardsD.W., and BisschopS.M. (2009). Differential emotional responses of varsity athletes to concussion and musculoskeletal injuries. Clin. J. Sport Med. 19, 13–19.
15.
EisenbergM.A., MeehanW.P., and MannixR. (2014). Duration and course of post-concussive symptoms. Pediatrics, 133, 999–1006.
16.
Aaro JonssonC., EmanuelsonI.M., and Charlotte SmedlerA. (2014). Variability in quality of life 13 years after traumatic brain injury in childhood. Int. J. Rehabil. Res. 37, 317–322.
17.
LauB.C., KontosA.P., CollinsM.W., MuchaA., and LovellM.R. (2011). Which on-field signs/symptoms predict protracted recovery from sport-related concussion among high school football players?. Am. J. Sports Med. 39, 2311–2318.
18.
CrichtonA., BablF., OakleyE., GreenhamM., HearpsS., DelzoppoC., HutchisonJ., BeauchampM., and AndersonV. (2017). Prediction of multidimensional fatigue after childhood brain injury. J. Head Trauma Rehabil. 32, 107–116.
19.
CrichtonA., AndersonV., OakleyE., GreenhamM., HearpsS., DelzoppoC., BeauchampM.H., HutchisonJ.S., GuerguerianA.M., BoutisK., and BablF.E. (2018). Fatigue following traumatic brain injury in children and adolescents: a longitudinal follow-up 6 to 12 months after injury. J. Head Trauma Rehabil. 33, 200–209.
20.
KempfJ., WerthE., KaiserP.R., BassettiC.L., and BaumannC.R. (2010). Sleep–wake disturbances 3∣years after traumatic brain injury. J. Neurol. Neurosurg. Psychiatry, 81, 1402–1405.
21.
KuppermannN., HolmesJ.F., DayanP.S., HoyleJ.D.Jr., AtabakiS.M., HolubkovR., NadelF.M., MonroeD., StanleyR.M., BorgialliD.A., BadawyM.K., SchunkJ.E., QuayleK.S., MahajanP., LichensteinR., LillisK.A., TunikM.G., JacobsE.S., CallahanJ.M., GorelickM.H., GlassT.F., LeeL.K., BachmanM.C., CooperA., PowellE.C., GerardiM.J., MelvilleK.A., MuizelaarJ.P., WisnerD.H., ZuspanS.J., DeanJ.M. and Wootton-GorgesS.L. (2009). Identification of children at very low risk of clinically-important brain injuries after head trauma: a prospective cohort study. Lancet, 374, 1160–1170.
22.
Biomarkers Definitions Working Group (2001). Biomarkers and surrogate endpoints: Preferred definitions and conceptual framework. Clin. Pharmacol. Ther. 69, 89–95.
23.
BeersS.R., BergerR.P., and AdelsonP.D. (2007). Neurocognitive outcome and serum biomarkers in inflicted versus non-inflicted traumatic brain injury in young children. J. Neurotrauma, 24, 97–105.
24.
BergerR.P., BeersS.R., RichichiR., WiesmanD., and AdelsonP.D. (2007). Serum biomarker concentrations and outcome after pediatric traumatic brain injury. J. Neurotrauma, 24, 1793–1801.
25.
LoT.Y., JonesP.A., and MinnsR.A. (2009). Pediatric brain trauma outcome prediction using paired serum levels of inflammatory mediators and brain-specific proteins. J. Neurotrauma, 26, 1479–1487.
26.
SpinellaP.C., DominguezT., DrottH.R., HuhJ., McCormickL., RajendraA., ArgonJ., McIntoshT., and HelfaerM. (2003). S-100beta protein-serum levels in healthy children and its association with outcome in pediatric traumatic brain injury. Crit. Care Med. 31, 939–945.
27.
BandyopadhyayS., HennesH., GorelickM.H., G., W.R. and Walsh-KellyC.M. (2005). Serum neuron-specific enolase as a predictor of short-term outcome in children with closed traumatic brain injury. Acad. Emerg. Med. 12, 732–738.
28.
LugonesM., ParkinG., BjelosevicS., TakagiM., ClarkeC., AndersonV., and IgnjatovicV. (2018). Blood biomarkers in paediatric mild traumatic brain injury: a systematic review. Neurosci .Biobehav. Rev, .87, 206–217.
29.
BergerR.P. (2006). The use of serum biomarkers to predict outcome after traumatic brain injury in adults and children. J. Head Trauma Rehabil. 21, 315–333.
HaqqaniA.S., HutchisonJ.S., WardR., and StanimirovicD.B. (2007). Biomarkers and diagnosis; protein biomarkers in serum of pediatric patients with severe traumatic brain injury identified by ICAT-LC-MS/MS. J. Neurotrauma, 24, 54–74.
32.
WilkinsonA.A., SimicN., FrndovaH., TaylorM.J., ChoongK., FraserD., CampbellC., DhananiS., KuehnS., BeauchampM.H., FarrellC., AndersonV., GuerguerianA.M., DennisM., SchacharR., and HutchisonJ.S. (2016). Serum biomarkers help predict attention problems in critically ill children with traumatic brain injury. Pediatr. Crit. Care Med. 17, 638–648.
33.
WilkinsonA.A., DennisM., SimicN., TaylorM.J., MorganB.R., FrndovaH., ChoongK., CampbellC., FraserD., AndersonV., GuerguerianA.M., SchacharR., and HutchisonJ. (2017). Brain biomarkers and pre-injury cognition are associated with long-term cognitive outcome in children with traumatic brain injury. BMC Pediatr. 17, 173.
34.
Anderson V., CatroppaC., MorseS., HaritouF., and RosenfeldJ. (2005). Functional plasticity or vulnerability after early brain injury?. . Pediatrics, 116, 1374–1382.
35.
ReillyP.L., SimpsonD.A., SprodR., and ThomasL. (1988). Assessing the conscious level in infants and young children: a paediatric version of the Glasgow Coma Scale. Childs Nerv. Syst. 4, 30–33.
36.
AdelsonP.D., PinedaJ., BellM.J., AbendN.S., BergerR.P., GizaC.C., HotzG., and WainwrightM.S. (2012). Common data elements for pediatric traumatic brain injury: recommendations from the working group on demographics and clinical assessment. J. Neurotrauma, 29, 639–653.
37.
AndersonJ.S., and FerransC.E. (1997). The quality of life of persons with chronic fatigue syndrome. J. Nerv. Ment. Dis. 185, 359–367.
38.
AndersonV., GodfreyC., RosenfeldJ., and CatroppaC. (2012). Predictors of cognitive function and recovery 10 years after traumatic brain injury in young children. Pediatrics, 129, e254–e261.
39.
Ewing-CobbsL., BloomD.R., PrasadM.R., WaughJ.K., CoxC.S.Jr., and SwankP.R. (2014). Assessing recovery and disability after physical trauma: the Pediatric Injury Functional Outcome Scale. J. Pediatr. Psychol. 39, 653–665.
40.
VarniJ.W., BurwinkleT.M., KatzE.R., MeeskeK., and DickinsonP. (2002). The PedsQL in pediatric cancer: reliability and validity of the Pediatric Quality Of Life Inventory Generic Core Scales, Multidimensional Fatigue Scale, and Cancer Module. Cancer, 94, 2090–2106.
41.
VarniJ.W., BurwinkleT.M., and SzerI.S. (2004). The PedsQL Multidimensional Fatigue Scale in pediatric rheumatology: reliability and validity. J. Rheumatol. 31, 2494–2500.
42.
PanepintoJ.A., TorresS., BendoC.B., McCavitT.L., DinuB., Sherman-BienS., Bemrich-StolzC., and VarniJ.W. (2014). PedsQL™ Multidimensional Fatigue Scale in sickle cell disease: feasibility, reliability, and validity. Pediatr. Blood Cancer, 61, 171–177.
43.
MacAllisterW.S., ChristodoulouC., TroxellR., MilazzoM., BlockP., PrestonT.E., BenderH.A., BelmanA., and KruppL.B. (2009). Fatigue and quality of life in pediatric multiple sclerosis. Mult. Scler. 15, 1502–1508.
44.
LimondJ., DorrisL., and McMillanT.M. (2009). Quality of life in children with acquired brain injury: parent perspectives 1-5 years after injury. Brain Inj. 23, 617–622.
45.
AndersonV., Le BrocqueR., IselinG., ErenS., DobR., DavernT., McKinlayL. and KenardyJ. (2012). Adaptive ability, behavior and quality of life pre and posttraumatic brain injury in childhood. Disabil. Rehabil. 34, 1639–1647.
46.
AndersonV., MorseS.A., KlugG., CatroppaC., HaritouF., RosenfeldJ., and PentlandL. (1997). Predicting recovery from head injury in young children: a prospective analysis. J. Int. Neuropsychol. Soc. 3, 568-580.
47.
StataCorp (2017). Stata statistical software: Release 15. StataCorp LP: College Station, TX.
48.
CrichtonA., OakleyE., BablF.E., GreenhamM., HearpsS., DelzoppoC., BeauchampM.H., HutchisonJ.S., GuerguerianA.M., BoutisK., and AndersonV. (2018). Predicting fatigue 12 months after child traumatic brain injury: child factors and postinjury symptoms. J. Int. Neuropsychol. Soc. 24, 224–236.
49.
AloisiF., CareA., BorsellinoG., GalloP., RosaS., BassaniA., CabibboA., TestaU., LeviG., and PeschleC. (1992). Production of hemolymphopoietic cytokines (il-6, il-8, colony-stimulating factors) by normal human astrocytes in response to IL-1 beta and tumor necrosis factor-alpha. J. Immunol, 149, 2358–2366.
50.
NittaT., AllegrettaM., OkumuraK., SatoK., and SteinmanL. (1992). Neoplastic and reactive human astrocytes express interleukin-8 gene. Neurosurg. Rev, 15, 203–207.
51.
ZhangL., LiH.Y., LiH., ZhaoJ., SuL., ZhangY., ZhangS.L., and MiaoJ.Y. (2011). Lipopolysaccharide activated phosphatidylcholine-specific phospholipase C and induced IL-8 and MCP-1 production in vascular endothelial cells. J. Cell. Physiol. 226, 1694–1701.
52.
PranzatelliM.R. (2018). Advances in biomarker-guided therapy for pediatric- and adult-onset neuroinflammatory disorders: Targeting chemokines/cytokines. Front Immunol, 9, 557.
53.
McClainC.J., CohenD., OttL., DinarelloC.A., and YoungB. (1987). Ventricular fluid interleukin-1 activity in patients with head injury. J. Lab. Clin. Med. 110, 48–54.
54.
TaupinV., ToulmondS., SerranoA., BenavidesJ., and ZavalaF. (1993). Increase in il-6, il-1 and TNF levels in rat brain following traumatic lesion. Influence of pre- and post-traumatic treatment with Ro5 4864, a peripheral-type (p site) benzodiazepine ligand. J. Neuroimmunol. 42, 177–185.
55.
WoodroofeM.N., SarnaG.S., WadhwaM., HayesG.M., LoughlinA.J., TinkerA. and CuznerM.L. (1991). Detection of interleukin-1 and interleukin-6 in adult rat brain, following mechanical injury, by in vivo microdialysis: evidence of a role for microglia in cytokine production. J. Neuroimmunol. 33, 227–236.
56.
LoT.Y., JonesP.A. ,and MinnsR.A. (2009). Pediatric brain trauma outcome prediction using paired serum levels of inflammatory mediators and brain-specific proteins. J. Neurotrauma, 26, 1479–1487.
57.
LoT.Y., JonesP.A., and MinnsR.A. (2010). Combining coma score and serum biomarker levels to predict unfavorable outcome following childhood brain trauma. J. Neurotrauma, 27, 2139–2145.
58.
PonsfordJ., SchönbergerM., and RajaratnamS.M. (2015). A model of fatigue following traumatic brain injury. J. Head Trauma Rehabil. 30, 277–282.
59.
NijhofS.L., MaijerK., BleijenbergG., UiterwaalC.S., KimpenJ.L,. and van de PutteE.M. (2011). Adolescent chronic fatigue syndrome: prevalence, incidence, and morbidity. Pediatrics, 127, e1169–e1175.
60.
BrownD.A., ElsassJ.A., MillerA.J., ReedL.E., and RenekerJ.C. (2015). Differences in symptom reporting between males and females at baseline and after a sports-related concussion: a systematic review and meta-analysis. Sports Med. 45, 1027–1040.
61.
KostyunR.O., and HafeezI. (2015). Protracted recovery from a concussion: a focus on gender and treatment interve, Maijer, K.,ntions in an adolescent population. Sports Health, 7, 52–57.
62.
ZemekR., BarrowmanN., FreedmanS.B., GravelJ., GagnonI., McGahernC., AglipayM., SanghaG., BoutisK., BeerD., CraigW., BurnsE., FarionK.J., MikrogianakisA., BarlowK., DubrovskyA.S., MeeuwisseW., GioiaG., Meehan IiiW.P., BeauchampM.H., KamilY., GroolA.M., HoshizakiB., AndersonP., BrooksB.L., YeatesK.O., VassilyadiM., KlassenT., KeightleyM., RicherL., DeMatteoC., and OsmondM.H. (2016). Clinical risk score for persistent postconcussion symptoms among children with acute concussion in the ED. JAMA, 315, 1014–1025.
63.
BergerR.P., PierceM.C., WisniewskiS.R., AdelsonP.D., ClarkR.S., RuppelR.A., and KochanekP.M. (2002). Neuron-specific enolase and S100B in cerebrospinal fluid after severe traumatic brain injury in infants and children. Pediatrics, 109, E31.
64.
BergerR.P., AdelsonP.D., PierceM.C., DulaniT., CassidyL.D., and KochanekP.M. (2005). Serum neuron-specific enolase, S100B, and myelin basic protein concentrations after inflicted and noninflicted traumatic brain injury in children. J. Neurosurg. 103, Suppl 1, 61–68.
65.
PapaL., and WangK.K. (2017). Raising the bar for traumatic brain injury biomarker research: methods make a difference. J. Neurotrauma, 34, 2187–2189.
66.
WoodcockT., and Morganti-KossmannM.C. (2013). The role of markers of inflammation in traumatic brain injury. Front. Neurol. 4, 18.
67.
EiserC., and MorseR. (2001). Can parents rate their child's health-related quality of life?. Results from a systematic review. Qual. Life Res. 10, 347–357.
68.
UptonP., LawfordJ., and EiserC. (2008). Parent-child agreement across child health-related quality of life instruments: a review of the literature. Qual. Life Res. 17, 895–913.
69.
HollandA.A., GravesD., GreenbergB.M., and HarderL.L. (2014). Fatigue, emotional functioning, and executive dysfunction in pediatric multiple sclerosis. Child. Neuropsychol. 20, 71–85.
70.
VarniJ.W., LimbersC.A., BryantW.P., and WilsonD.P. (2010). The PedsQL multidimensional fatigue scale in pediatric obesity: feasibility, reliability and validity. Int. J. Pediatr. Obes. 5, 34–42.
71.
WhitsettS.F., GudmundsdottirM., DaviesB., McCarthyP., and FriedmanD. (2008). Chemotherapy-related fatigue in childhood cancer: correlates, consequences, and coping strategies. J. Pediatr. Oncol. Nurs. 25, 86–96.
72.
CrichtonA., BablF., OakleyE., GreenhamM., HearpsS., DelzoppoC., HutchinsonJ., BeauchampM.H., and AndersonV. (2016). Prediction of multi-dimensional fatigue following child brain injury J. Head Trauma Rehabil. 21.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
